Dr. Nguyet A Le-Lindqwister, MD

Claim this profile

Illinois Cancer Care

Studies Lymphoma
Studies Hodgkin's Lymphoma
4 reported clinical trials
10 drugs studied

Area of expertise

1Lymphoma
Nguyet A Le-Lindqwister, MD has run 1 trial for Lymphoma. Some of their research focus areas include:
Stage I
Stage IV
Stage III
2Hodgkin's Lymphoma
Nguyet A Le-Lindqwister, MD has run 1 trial for Hodgkin's Lymphoma. Some of their research focus areas include:
Stage I
Stage IV
Stage III

Affiliated Hospitals

Image of trial facility.
Illinois Cancer Care

Clinical Trials Nguyet A Le-Lindqwister, MD is currently running

Image of trial facility.

Tucatinib + T-DM1

for Breast Cancer

This study is being done to see if tucatinib with ado-trastuzumab emtansine (T-DM1) works better than T-DM1 alone to help patients who have a specific type of breast cancer called HER2 positive breast carcinoma. The breast cancer in this study is either metastatic (spread into other parts of the body) or cannot be removed completely with surgery. Patients in this study will be randomly assigned to get either tucatinib or placebo (a pill with no medicine). This is a blinded study, so neither patients nor their doctors will know whether a patient gets tucatinib or placebo. All patients in the study will get T-DM1, a drug that is often used to treat this cancer. Each treatment cycle lasts 21 days. Patients will swallow tucatinib pills or placebo pills two times every day. Patients will get T-DM1 injections from the study site staff on the first day of every cycle.
Recruiting1 award Phase 36 criteria

More about Nguyet A Le-Lindqwister, MD

Clinical Trial Related5 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Nguyet A Le-Lindqwister, MD has experience with
  • Brentuximab Vedotin
  • Doxorubicin
  • Dacarbazine
  • Nivolumab
  • Olaratumab
  • Tucatinib
Breakdown of trials Nguyet A Le-Lindqwister, MD has run
Lymphoma
Hodgkin's Lymphoma
Soft Tissue Sarcoma
Sarcoma
Breast Cancer

Other Doctors you might be interested in

Wenqing ZhangIllinois Cancer Care
Jane Liu, MDIllinois Cancer Care
David HakimianGSK Investigational Site

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Nguyet A Le-Lindqwister, MD specialize in?
Nguyet A Le-Lindqwister, MD focuses on Lymphoma and Hodgkin's Lymphoma. In particular, much of their work with Lymphoma has involved Stage I patients, or patients who are Stage IV.
Is Nguyet A Le-Lindqwister, MD currently recruiting for clinical trials?
Yes, Nguyet A Le-Lindqwister, MD is currently recruiting for 1 clinical trial in Peoria Illinois. If you're interested in participating, you should apply.
Are there any treatments that Nguyet A Le-Lindqwister, MD has studied deeply?
Yes, Nguyet A Le-Lindqwister, MD has studied treatments such as Brentuximab Vedotin, Doxorubicin, Dacarbazine.
What is the best way to schedule an appointment with Nguyet A Le-Lindqwister, MD?
Apply for one of the trials that Nguyet A Le-Lindqwister, MD is conducting.
What is the office address of Nguyet A Le-Lindqwister, MD?
The office of Nguyet A Le-Lindqwister, MD is located at: Illinois Cancer Care, Peoria, Illinois 61615 United States. This is the address for their practice at the Illinois Cancer Care.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top